Response to Lai

Affiliations

¹ McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
² Mayo Clinic, Jacksonville, Florida, USA.
³ University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
⁴ Furiex Pharmaceuticals, Inc., an Affiliate of Allergan Plc, Madison, New Jersey, USA.

Comment

Brooks D Cash et al. Am J Gastroenterol. 2019 Jul.

. 2019 Jul;114(7):1177-1178.

doi: 10.14309/ajg.0000000000000312.

¹ McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
² Mayo Clinic, Jacksonville, Florida, USA.
³ University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
⁴ Furiex Pharmaceuticals, Inc., an Affiliate of Allergan Plc, Madison, New Jersey, USA.

No abstract available

Comment on

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS. Cash BD, et al. Am J Gastroenterol. 2017 Feb;112(2):365-374. doi: 10.1038/ajg.2016.542. Epub 2016 Dec 6. Am J Gastroenterol. 2017. PMID: 27922029 Free PMC article. Clinical Trial.
Safety of Eluxadoline Use.
Lai SW. Lai SW. Am J Gastroenterol. 2019 Jul;114(7):1176-1177. doi: 10.14309/ajg.0000000000000205. Am J Gastroenterol. 2019. PMID: 30920418 No abstract available.